| dc.contributor.author | Moghimi, Mahsa | en_US |
| dc.contributor.author | Parvardeh, Siavash | en_US |
| dc.contributor.author | Moini Zanjani, Taraneh | en_US |
| dc.contributor.author | Ghafghazi, Shiva | en_US |
| dc.date.accessioned | 1399-07-09T08:24:29Z | fa_IR |
| dc.date.accessioned | 2020-09-30T08:24:29Z | |
| dc.date.available | 1399-07-09T08:24:29Z | fa_IR |
| dc.date.available | 2020-09-30T08:24:29Z | |
| dc.date.issued | 2016-09-01 | en_US |
| dc.date.issued | 1395-06-11 | fa_IR |
| dc.date.submitted | 2016-09-25 | en_US |
| dc.date.submitted | 1395-07-04 | fa_IR |
| dc.identifier.citation | Moghimi, Mahsa, Parvardeh, Siavash, Moini Zanjani, Taraneh, Ghafghazi, Shiva. (2016). Protective effect of α-terpineol against impairment of hippocampal synaptic plasticity and spatial memory following transient cerebral ischemia in rats. Iranian Journal of Basic Medical Sciences, 19(9), 960-969. doi: 10.22038/ijbms.2016.7596 | en_US |
| dc.identifier.issn | 2008-3866 | |
| dc.identifier.issn | 2008-3874 | |
| dc.identifier.uri | https://dx.doi.org/10.22038/ijbms.2016.7596 | |
| dc.identifier.uri | http://ijbms.mums.ac.ir/article_7596.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/340832 | |
| dc.description.abstract | <strong><em>Objective(s)</em></strong>: Cerebral ischemia is often associated with cognitive impairment. Oxidative stress has a crucial role in the memory deficit following ischemia/reperfusion injury. α-Terpineol is a monoterpenoid with anti-inflammatory and antioxidant effects. This study was carried out to investigate the effect of α-terpineol against memory impairment following cerebral ischemia in rats. <br/><strong><em>Materials and Methods: </em></strong>Cerebral ischemia was induced by transient bilateral common carotid artery occlusion in male Wistar rats. The rats were allocated to sham, ischemia, and α-terpineol-treated groups. α-Terpineol was given at doses of 50, 100, and 200 mg/kg, IP once daily for 7 days post ischemia. Morris water maze (MWM) test was used to assess spatial memory and in vivo extracellular recording of long-term potentiation (LTP) in the hippocampal dentate gyrus was carried out to evaluate synaptic plasticity. Malondialdehyde (MDA) was measured to assess the extent of lipid peroxidation in the hippocampus. <br/><strong><em>Results:</em></strong> In MWM test, α-terpineol (100 mg/kg, IP) significantly decreased the escape latency during training trials (<em>P</em><0.01). In addition, α-terpineol increased the number of crossings over the platform location and decreased average proximity to the target in probe trial (<em>P</em><0.05). In electrophysiological recording, α-terpineol (100 mg/kg) facilitated the induction of LTP in the hippocampus which was persistent over 2 hr. α-Terpineol (100 and 200 mg/kg) also significantly lowered hippocampal MDA levels in rats subjected to cerebral ischemia. <br/><strong><em>Conclusion:</em></strong> These findings indicate that α-terpineol improves cerebral ischemia-related memory impairment in rats through the facilitation of LTP and suppression of lipid peroxidation in the hippocampus. | en_US |
| dc.format.extent | 1218 | |
| dc.format.mimetype | application/pdf | |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | Mashhad University of Medical Sciences | en_US |
| dc.relation.ispartof | Iranian Journal of Basic Medical Sciences | en_US |
| dc.relation.isversionof | https://dx.doi.org/10.22038/ijbms.2016.7596 | |
| dc.subject | α-Terpineol | en_US |
| dc.subject | Cerebral ischemia | en_US |
| dc.subject | Long-term potentiation | en_US |
| dc.subject | Memory | en_US |
| dc.subject | Oxidative stress | en_US |
| dc.subject | Rats | en_US |
| dc.title | Protective effect of α-terpineol against impairment of hippocampal synaptic plasticity and spatial memory following transient cerebral ischemia in rats | en_US |
| dc.type | Text | en_US |
| dc.type | Original Article | en_US |
| dc.contributor.department | Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran | en_US |
| dc.contributor.department | Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran | en_US |
| dc.contributor.department | Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran | en_US |
| dc.contributor.department | School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran | en_US |
| dc.citation.volume | 19 | |
| dc.citation.issue | 9 | |
| dc.citation.spage | 960 | |
| dc.citation.epage | 969 | |
| nlai.contributor.orcid | 0000-0002-5001-4633 | |